South Africa suspends AstraZeneca COVID-19 vaccines after study finds limited impact on variant

South Africa has temporarily suspended use of a coronavirus vaccine developed by AstraZeneca and Oxford University after preliminary findings showed the jab had little impact on curbing mild to moderate infections due to a variant strain.